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Male F344 5-week-old rats were X-irradiated, and 16 weeks after the first dose. azoxymethane (AOM) was in-
jected or 2-amino-l-methyl-6-phenylimidazo [4,5-b ]pyridine (PhIP) was given by intragastric intubation. Tumors 
in the pylonls of the glandular stomach were observed in 4 out of the 29 animals receiving X-rays + AOM and 
in 4 out of the 25 animals receiving X-rays + PhIP, 12 months after administration. No such lesions were found 
in the chemical or X-ray alone groups. Intestinal metaplasia and some induced tumors were positive for CDX2. 
It was concluded that the presence of intestinal metaplasia may increase sensitivity to the induction of gastric tu-
mors by colon carcinogens. 
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Intestinal metaplasia 
Based on investigations in humans, intestinal 
metaplastic changes in the stomach have been con-
sidered precancerous lesions or a predisposing condi-
tion for differentiated gastric carcinoma development 
(1-7). However, we experimentally investigated an 
inverse relationship bet\veen quantity of intestinal 
metaplasia, with or without Paneth cells, and gastric 
tumor development, and established that its presence 
does not exert a positive influence on induction of 
gastric neoplasia by N-methyl-N'-nitro-N-
nitrosoguanidine (MNNG) or N-methylnitrosoure 
(MNU) in rats (8.9). The situation is complex, how-
ever. because Nakagawa et al. have indicated that col-
orectal mucosa implanted into the glandular stomach, 
like the intrinsic large intestine, is sensitive to 
tumorigenesis caused by the colon carcinogen, 1,2-
diInethylhydrazine (OMH). in contrast to normal gas-
tric mucosa (10). Furthermore, \ve reported that 
induction of intestinal metaplastic mucosa in the 
glandular stomach is associated with susceptibility to 
tmnorigenesis due to DMH 01,12). 
The present study was designed to further examine 
whether intestinal metaplasia might be a target for 
azoxymethane (AOM) or 2-amino-I-methyl-6-
phenylimidazo [4.5-b ]pyridine (PhIP)-induction of 
malignant tumors in the glandular stomach. 
lVlaterials and Methods 
Animals. Male F344/DuCIj rats, 5 weeks of age at 
the commencement, were purchased from Charles 
River and housed five to a polycarbonate cage under 
constant conditions of temperature (24 ± 2°C) and 
relative humidity (55 ± 10%), with a 12: 12-hour 
light-dark cycle. The animals were maintained 
according to the "Guide for the Care and Use of Lab-
oratory Anilnals" established by Hiroshima Universi-
ty. All rats were provided with a commercial diet 
(MF: Oriental Yeast Co., Tokyo, Japan) and tap water 
ad libitum. 
The animals \vere X-in-adiated according to the 
method described previously (8,9,13). with t\VO X-ray 
doses of lOGy each at a three-day interval (total 
dose. 20 Gy). 
Four months after the first in-adiation, initiation of 
azoxymethane (AOM, Sigma Chemical Co.. St. 
Louis, tvl0) (14.15) or 2-amino-I-methyl-6-pheny-
305 
S. Kashi\vabara et al. 
limidazo [4,5-b ]pyridine (PhIP, NARD. Amagasaki. 
Japan), both of which induce colon cancer (16-19), 
was cOlnmenced. AOM was given in weekly subcuta-
neous injections of 15 mg/kg body wt for 3 weeks, 
while PhlP was administered every 2 days, 3 times 
per week for a total of 10 doses of 75 mg/kg body wt 
by intragastric intubation. 
Experimental Procedure. A total of 169 rats was 
divided into 6 groups. The animals in Groups 1 to 3 
were X-ray irradiated. Those in Groups 1 and 4 were 
given PhIP. while Groups 2 and 5 received AOM. All 
were fed a nonnal MF diet throughout the experi-
mental period. The animals were killed and autopsied 
when they became moribund and all remaining rats 
were killed by ether anesthesia 12 months after the 
initial chemical carcinogen treatment. The stomach, 
and the small and large intestinal tracts were 
removed, opened and extended on cardboard for 
inspection. The location of individual tumors was 
recorded by measuring the distance from the pyloric 
ring in the small intestine and from the anus in the 
large intestine. The numbers and sizes of individual 
tumors \vere also noted. Whole tissues were fixed in 
10% neutral formalin. Alkaline phosphatase (ALP)-
positive foci in the gastric mucosa were detected by 
the naphthol-AS-MX-phosphate-fast blue RR stain-
ing method (20) and the numbers of ALP-positive 
foci in the whole gastric mucosa per rat were counted 
under a dissection microscope with a double-blind 
protocol. Sections of paraffin-embedded tissue were 
routinely stained \\lith hematoxylin and eosin, and for 
clarification, when necessary, \\"ith periodic acid 
Schiff-Alcian-blue (AB-PAS). Other organs were 
relTIoved, fixed in 10% neutral formalin and stained 
with HE. 
Intestinal metaplasias were categorized using the 
following histological criteria (21.22): type A, gastric 
mucosa with goblet cells \vhich were positive for AB-
PAS: type B, intestinal-type crypts without Paneth 
cells or type C, intestinal metaplasia with Paneth cells 
(alkaline phosphatase-positive foci). Using these crite-
ria. the numbers of metaplastic crypts were counted 
separately for 2 sections through the lesser curvature 
(pylorus) and 4 through the greater curvature (fundus) 
in a double-blind fashion. Tumors in the stomach, 
small intestine and large intestine were classified into 
two types. adenoma, especially stomach, atypical 
hyperplasia (ATP, shown in Fig.l) and adenocarcino-
mas invading the musclaris mucosa or further, and also 
into 1\vo histological types, the well-di fferentiated 
(Fig.2) and poorly-differentiated types (Fig.3). the lat-
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Fig. 1 - Atypical hyperplasia shown proliferation of atypical 
glands in mucosa, x I 00, HE staining. 
Fig. 2 - Well differentiated adenocarcinoma shown atypical 
glands invaded all the layer or the gastric wall, x I 00, HE 
staining. 
ter including both mucinous and signet ring cell forms. 
Immunohistochemistry. Paraffin-embedded sec-
tions were deparaffinized in xylene, and rehydrated 
through graded alcohols. A 0.05 M PBS buffer was 
used to prepare solutions and for \\lashes between the 
various steps. Incubations were performed in a 
humidified chamber. Three-J.lm-thick sections \vere 
treated for 30 min at room temperature with 2% BSA 
and incubated with primary antibodies against CDX2 
(diluted 1 :50: Biogenex CDX2-88) (23) for I hour at 
Fig. 3 - Signet ring carcinoma, x40, HE staining. 
room temperature. For each case, negative controls 
were performed on serial sections whereby incuba-
tion with the primary antibody was omitted. All slides 
were then exposed to the secondary antibody, biotiny-
lated horse anti-universal-monkey IgG (Vectastain 
Universal Quick Kit Vector Laboratories, Ca., Cata-
log No. PK-8800) and peroxidase-conjugated strepta-
vidin complexes. Peroxidase activity was visualized 
by treatment with H")O,) and diaminobenzidine for 5 
min. At the last step, the sections were counterstained 
Table I - Body and organ v~'eights 
Group r..'lean Body 
survival \Veight (g) Heart 
Tumor Induction by Colon Carcino!Zen in Rat Gastric Mucosa 
with hematoxylin for 1 min. CDX2-positive cells 
\vere observed. 
Statistical anaZvsis. The significance of differ-
ences in numerical data was evaluated by using the 
chi-squared test and Student's t test. 
Results 
Mean survival did not significantly ditTer among 
the groups. Body weights in the chemical carcinogen 
treatment groups were significantly decreased as 
compared to those in the control group (Table I). 
Heart weights \vere lower in the X-ray + PhIP and x-
ray and PhIP groups and I iver in the AOM, kidneys in 
the PhIP and AOM, testes in the AOM and spleens in 
the X-ray + PhlP and X-ray groups were significant-
ly smaller than those of the controls. On the other 
hand, spleen \\:eights signiticantly increased. Relative 
liver, kidney, and testis weights (relative weight: 
organ weight/body weight x 1,000) in the X-ray + 
PhIP group and relative spleen weights in the AOM 
group were significantly enlarged, \vhile in the X-ray 
goup they were smaller than those in the controls 
(Table I I). 
The incidence and number of areas of intestinal 
metaplasias in the X-ray irradiated groups were sig-
nificantly increased as compared to those in the non-
irradiated groups (Tables III and IV). Incidences in 
Organ \veight (g) 
Liver Kidney Adrenal Testis Spleen 
X-ray+PhIP 356±32 386±50** 1. I 2±O.09** 11.6± 1.5 2.47±0.35 O.O52±0.006 3.24±0.IS O.6~O.13** 
X-ray+AOrvt 337±50 415±37** 1.19±O.1 t 12.0±3.0 2.36±O.21 O.OS4±0.1 01 3.36±O.34 O.80±0.42 
X-ray 365±1l 433±35 1.14±O.13** 11.7±1.1 2.37±O.19 O.056±O.0 14 3.35±O.27 O.63±O.13** 
PhlP 364 425±26** 1.14±O.10** 11.3±l.O 2.29±O.23* O.063±O.O 12 3.21±O.30 O.79±O.10 
AOM 359±IO 427±23* 1.2 t±O.1 t t 1.2± 1.1 * 2.29±O.14* O.055±O.O 1 0 3.14±O.35** I.09±O.19** 
Control 364 452±33 1.26±O.12 12.2±1.3 2.43±O.20 O.O65±O.O15 3.39±O.29 0.S6±0.10 
*: Sign!fical11~v differencefrom COllIrol vallie (P<O.05) - **: Sigl1{/ical1l(r differel1ceji'olll C011lml vallie (P<O.Ol) 
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Table II - Relative weight* 
Group Heart Liver Kidney Adrenal Testis Spleen 
X-ray~PhIP 2.96±0.59 30.7±5.9** 6.56± 1.52** 0.139±0.031 8.61±1.92** 1.59±0.43 
X-ray+AO\1 2.88±0.26 29.1±8.2 5.69±0.38 O. 1 99±0 .226 8.16±1.04 1.96± 1.14 
X-ray 2.66±O.33 27.1±2.4 5.49±0.43 0.I31±O.037 7.76±0.61 1.47±O.42** 
PhIP 2.68±0.18 26.7±1.9 5.41±0.72 0.149±O.031 7.58±0.76 1.88±O.30 
AOM 2.83±0.23 26.1±1.8 5.37±0.3J 0.128±0.021 7.35±O.84 2.55±O.46** 
Control 2.78±0.24 26.9±1.7 5.39±0.37 O. 144±0.03 I 7.52±0.68 1.91±O.20 
*:OrgClIl weight/Body weight x 1.000 - **: Sign{!icant(v difference/rom Control vallie (P<{).OI). 
Table III - Incidence of Intestinal metaplasia (%) 
Group ALP Pylorus Pylorus+Fundus 
A B C Total A B C Total 
X-ray+PhIP 81 32 91 59 95 36 95 50 95 
X-ray+AOM 66 26 78 65 82 26 87 74 87 
X-ray 66 0 94 47 94 0 94 50 94 
PhIP 0 8 0 0 8 8 8 0 25 
AO!v1 0 17 8 0 25 17 25 0 33 
Control 0 0 0 0 0 0 II 0 11 
ALP: Alkaline phosphatase positive inteslil1almetaolasia - A: Goblet cells wilh the gas/ric Il1IlSOSa 
B: Intestinal ~\pe crypt withom Pane/II cells - C: Intestinal Ope crypt with Paneth cells. 
the X-ray groups "vere 84-95%, and in the non-irradi-
ated groups were only 11-330/0. The number of type B 
l11etaplasias and totals in the X-ray groups were sig-
nificantly increased, and type C lesions were also 
more common in the X-ray + AOM and X-ray alone 
groups than in the controls (Table IV). 
The first tumor appeared at 204 days, in an X-ray 
+ AOM animal. Total tumors in the AOM groups 
were significantly more numerous than in the PhlP 
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groups. Gastric tumors in the glandular stomach 
were observed in four out of the 25 (17%, three ATP. 
one adenocarcinoma) X-ray + PhIP animals, and 
four out of the 29 (10%. one ATP and three adeno-
carcinomas) X-rays + AOM animals. One signet 
ring cell carcinoma was found in this group. All 
other tumors in the glandular stomach were well-dif-
ferentiated without goblet cells or mucin and were 
located in the middle or upper portion. Nuclei of 
Tumor Induction by Colon Carcinogen in Rat Gastric T\lucosa 
Table IV - Mean number of intestinal metaplasia 
Group ALP Pylorus Pylorus+Fundus 
Group A B C Total A B C Total 
X-ray+PhIP 19.1±26.4 0.6± 1.1 6.9±5.S* 104± 1.8 8.9±7.3* 0.6±1.1 704±6.2* I.S±1.9 9.5±8.2** 
X-ray+AO!\-1 25.0±42.2* Oo4±0.8 804±7.7** 2.0±2.2* 10.9±9.3** 0.4±0.8 9.1±7.5** 2.4±2.2* 11.9±8. 7** 
X-ray 11.4± 18.9 0 9.8±10.0** 1.8±304 11.2±IIo4** 0 IO.7± 1 0.9** 2.3±3. 7* 12. 7± 12.6** 
PhIP 0 O.I±O.3 O.8±2.6 0 O.8±2.6 0.I±03 1.1±2.8 0 1.2±2.8 
AOt\.1 0 0.5± 104 O.2±0.6 0 0.7±0.6 0.5±lo4 Oo4±0.8 0 O.9±1.5 
Control 0 0 0 0 0 0 O.l±O.3 0 0.1±0.3 
*: Sigl1{fica11l(1' difference/rom Con/rot value (P<O, 05) - **: Sigl/[fican/~\' difference ji-om Control wt/ue (P<O,Of) 
intestinal metaplasia (Fig.4), and the signet ring cell 
carcinoma (Fig.5) were positive for COX2 by 
immunohistochemistry. On the other hand. the cyto-
plasm of a \vell-differentiated adenocarcinoma was 
positive (Fig.6). No gastric tumors were observed in 
the other groups (Table V). 
The incidence of small intestinal tumors was 28% 
and 30/0 in the X-ray+AOM and AOM groups. respec-
tively. The more frequent colon tumors were the mul-
tiple and the papillary and polypoid types. The inci-
deIlCe of colon tumors was 8%. 12%, 79% and 72% 
Fig .... - CDX-2 positive nuclei were observed in glands of intesti-
nal metaplasia, xlOO, CDX-2 antibody staining. 
in the X-ray + PhlP. PhIP, X-ray + AOrv1 and AONI 
groups, respectively. and the number of tumors was 
0.08 ± 0.28, 0.12 ± 0.3. 1.31 ± 0.97 and 1.17 ± 1.04. 
respectively (Table V). The incidences of signet ring 
cell carcinomas \vere 2 (70/0) in the X-ray + AOM and 
5 (19%) in the AOM groups. Aberrant crypt foci were 
observed in all of the chemical carcinogen-treated 
groups (data not shown). 
Pancreas (17-38%) and skin tumors (6-28%) also 
developed after X-ray treatments. Three kidney 
tumors w'ere found in the X-ray + PhIP group. three 
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fig. 6 - CDX-2 positive cytoplasm was observed in well ditTeren-
tiated adenocarcinoma x 200, CDX-2 antibody staining. 
ear duct tumors, one bone and two liver tumors in the 
X-ray + AOM group, and one tail papilloma in the 
PhIP group (Table V). 
Discussion 
In the present experiment, induction of intestinal 
Table V - Incidence and number of colon tumors 
No Total Gatsric Small 
metaplastic mucosa in the glandular stomach \vas 
associated with susceptibility to tumorigenesis 
induced by PhIP and AOM, in contrast to non-sus-
ceptible non11al gastric mucosa. In earlier studies, 
regression analysis of gastric tumors per rat against 
the frequency of intestinal metaplasia, vvith or vvith-
out Paneth cells. yielded a significant inverse rela-
tionship. suggesting that the development of intesti-
nal metaplasia and gastric tumors might be indepen-
dent (8,9). Previously. we reported that intestinal 
metaplasia is not susceptible to gastric tumor induc-
tion by MNNG and MNU (8,9) and that colonic 
mucosa transplanted into gastric mucosa lacks sus-
ceptibility to these carcinogens when given orally 
(24,25). Intestinal metaplasia or co]orectal mucosa 
implants into the glandular stomach are sensitive to 
DMH carcinogenicity, whereas the normal gastric 
mucosa is not (10). Thus. it \-vould appear that areas 
of intestinal metaplasia induced by X-ilTadiation 
might be susceptible to damage due to carcinogens 
targeting the large intestine. In the present experi-
ment. CDX-2 appeared in intestinal metaplasia and 
in some of the gastric tumors. CDX-2 is not expressed 
in the normal stomach but is highly expressed in the 
nonnal intestine and intestinal metaplasia (23,27) and 
carcinoma of the stomach, indicating its involvement 
in these lesions. So, it is considered that some of the 
gastric tumors in this experiment might have been 
caused by intestinal metaplasia and/or circumstances 
Colon tumor Pancreas Skin Other (%) 
(%) (%) intestine Incidence Number (%) (%) 
(%) (%) per rat 
X-ray+PhIP 25 16(64) 4(17) 0 2(8) 0.O8±0.28 8(32) 7(28) 3( 12) Kidney 3 
X-ray+AOM 29 27(93) 4(10) 8(28) 23(79) 1.31±0.97 5(17) 3(10) 6(21) Ear duct 3 
Liver 2 Bone 1 
X-ray 32 15(47) 0 0 0 0 12(38) 2(6) 2(6) Squamous 
cell carcinoma I 
Papilloma 1 
PhlP 25 4(16) 0 0 3(12) 0.12±0.33 0 0 1 Tail papillomal 
AOM 28 23(79) 0 1(3) 21 (72) 1. I 7±1.04 0 0 2(9) Liver 1 
Testis 1 
Control 30 0 0 0 0 0 0 0 0 
*:Sign(tican'~F difference/i'DIn X-r'~v grollp (P<O.05) - a: SignijicautZF difference (P<O.05) - h: Sigl/i{icantZv difference (P<O.Ol) 
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of intestinal metaplasia. 
\Ve must consider the alternative possibility that 
the etIects of irradiation and DMH and other colon 
carcinogens on glandular stomach epithelial cells are 
additive or synergistic. Tatemichi et al. reported that 
the cytochrome P450 monooxygenase 1 A 1 expressed 
in intestinal metaplasia, and carcinogen activation by 
lA 1 enzynles expressed in the gastric mucosa, may 
contribute to carcinogenesis of the stomach (28). It 
appears likely that intestinal mucosal stem cells are 
susceptible to colon carcinogenesis, independently of 
the administration route or their location. Thus, the 
intestinal mucosal phenotype appears to be the most 
inlportant determinant of response to colon carcino-
gens. rather than the intestinal macro-environment 
itself. 
In summary, the presence of intestinal metaplasia. 
\vith or \vithout Paneth cells, may increase the sensi-
tivity of the stomach to the induction of tumors by' 
carcinogens like DMH, AOM or PhIP, but not by 
MNNG or MNU. The protocol used in the present 
experiment may provide a new approach for distin-
guishing bet\veen developmental events associated 
with intestinal metaplasia and gastric tumors. 
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